| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.3B | $7.4B | $6.6B | $5.7B | $5.0B | $1.2B | $3.4B | $3.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B |
| SG&A Expense | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.7B | $0.6B |
| Operating Income | $2.0B | $1.6B | $1.2B | $0.9B | $0.7B | $0.6B | $1.0B | $1.3B |
| Net Income | $1.5B | $1.2B | $0.8B | $0.5B | $0.3B | $0.3B | $0.3B | $0.2B |
| EPS (Basic) | $3.73 | $2.83 | $1.85 | — | — | — | $0.71 | $0.45 |
| EPS (Diluted) | $3.71 | $2.81 | $1.83 | — | — | — | $0.70 | $0.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.2B | $10.5B | $10.4B | $10.3B | $10.2B | $11.4B | $17.6B | $18.7B |
| Current Assets | $3.8B | $3.4B | $3.3B | $3.1B | $2.7B | $3.7B | $5.8B | $6.6B |
| Cash & Equivalents | $0.7B | $0.6B | $0.6B | $0.8B | $0.7B | $1.6B | $1.6B | $2.3B |
| Total Liabilities | $5.8B | $6.0B | $6.4B | $6.7B | $6.7B | $7.9B | $13.0B | $13.1B |
| Current Liabilities | $1.8B | $1.5B | $1.8B | $1.5B | $1.3B | $1.7B | $4.1B | $3.5B |
| Stockholders' Equity | $5.4B | $4.6B | $4.0B | $3.6B | $3.5B | $3.6B | $4.6B | $5.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.9B | $1.3B | $0.9B | $0.7B | $0.4B | $0.0B | $0.4B | $0.2B |
| Investing Cash Flow | $-0.4B | $-0.3B | $-0.2B | $-0.1B | $0.1B | $0.3B | $0.6B | $0.6B |
| Capital Expenditures | $0.5B | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.6B | $0.8B |
| Financing Cash Flow | $-1.3B | $-1.0B | $-0.9B | $-0.5B | $-1.4B | $-0.4B | $-1.6B | $-0.6B |